We are live on
!
Find out more
PCM
Penserra Capital Management Portfolio holdings
AUM
$8.52B
1-Year Est. Return
37.76%
This Fund
S&P 500
This Quarter
Est. Return
+9.48%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.41B
AUM Growth
+$1.18B
(+28%)
Cap. Flow
+$984M
Cap. Flow
% of AUM
18.18%
Top 10 Holdings %
Top 10 Hldgs %
20.49%
Holding
1,162
New
152
Increased
695
Reduced
244
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$64.8M |
| 2 |
JD.com
JD
|
+$44.9M |
| 3 |
Mercado Libre
MELI
|
+$40.5M |
| 4 |
NetEase
NTES
|
+$38M |
| 5 |
KE Holdings
BEKE
|
+$21.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Futu Holdings
FUTU
|
+$21.6M |
| 2 |
Trip.com Group
TCOM
|
+$20.5M |
| 3 |
AOD
abrdn Total Dynamic Dividend Fund
AOD
|
+$12.1M |
| 4 |
Gabelli Dividend & Income Trust
GDV
|
+$12M |
| 5 |
EFR
Eaton Vance Senior Floating-Rate Fund
EFR
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 33.21% |
| 2 | Technology | 22.71% |
| 3 | Communication Services | 13.35% |
| 4 | Financials | 4.97% |
| 5 | Industrials | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
826
DELISTED
bluebird bio
BLUE
| $45K | ﹤0.01% |
117
-2
| -2% | -$985 |
|
827
Enphase Energy
ENPH
$5.53B
| $45K | ﹤0.01% |
281
+43
| +18% | +$7.72K |
|
828
Expeditors International
EXPD
$23.2B
| $45K | ﹤0.01% |
418
+64
| +18% | +$6.16K |
|
829
W.W. Grainger
GWW
$60.2B
| $44K | ﹤0.01% |
111
+16
| +17% | +$6.18K |
|
|
IGMS
830
DELISTED
IGM Biosciences
IGMS
| $44K | ﹤0.01% |
575
+20
| +4% | +$1.82K |
|
831
Waters Corp
WAT
$39.9B
| $44K | ﹤0.01% |
155
+24
| +18% | +$6.55K |
|
|
RVNC
832
DELISTED
Revance Therapeutics, Inc.
RVNC
| $44K | ﹤0.01% |
1,610
+85
| +6% | +$2.35K |
|
|
DRNA
833
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $44K | ﹤0.01% |
1,725
+5
| +0.3% | +$128 |
|
834
Broadridge
BR
$19B
| $43K | ﹤0.01% |
283
+40
| +16% | +$5.91K |
|
835
Inovio Pharmaceuticals
INO
$69M
| $43K | ﹤0.01% |
390
+61
| +19% | +$8.02K |
|
836
MarketAxess Holdings
MKTX
$5.72B
| $43K | ﹤0.01% |
88
+12
| +16% | +$6.4K |
|
837
Seagate
STX
$184B
| $43K | ﹤0.01% |
563
+88
| +19% | +$6.12K |
|
|
COUP
838
DELISTED
Coupa Software Incorporated
COUP
| $43K | ﹤0.01% |
171
+27
| +19% | +$8.51K |
|
|
CTXS
839
DELISTED
Citrix Systems Inc
CTXS
| $43K | ﹤0.01% |
310
+50
| +19% | +$6.7K |
|
840
Kura Oncology
KURA
$850M
| $42K | ﹤0.01% |
1,495
+195
| +15% | +$6.17K |
|
841
Seres Therapeutics
MCRB
$48.9M
| $42K | ﹤0.01% |
103
-2
| -2% | -$921 |
|
842
Madrigal Pharmaceuticals
MDGL
$11.8B
| $42K | ﹤0.01% |
365
+5
| +1% | +$583 |
|
843
Markel Group
MKL
$23.2B
| $42K | ﹤0.01% |
37
+8
| +28% | +$8.63K |
|
844
Tyler Technologies
TYL
$12.8B
| $42K | ﹤0.01% |
100
+16
| +19% | +$6.91K |
|
845
Genuine Parts
GPC
$18.7B
| $41K | ﹤0.01% |
361
+56
| +18% | +$5.96K |
|
846
BioCryst Pharmaceuticals
BCRX
$2.4B
| $40K | ﹤0.01% |
4,000
-120
| -3% | -$1.24K |
|
847
Fair Isaac
FICO
$22.5B
| $40K | ﹤0.01% |
83
+19
| +30% | +$9.03K |
|
848
Ironwood Pharmaceuticals
IRWD
$714M
| $40K | ﹤0.01% |
3,650
-80
| -2% | -$845 |
|
849
MacroGenics
MGNX
$257M
| $40K | ﹤0.01% |
1,270
-40
| -3% | -$971 |
|
850
NetApp
NTAP
$37.2B
| $40K | ﹤0.01% |
558
+88
| +19% | +$5.92K |
|
Similar funds
GRQ
IC
NB
DM
ACM
FT
NW
AAF
Penserra Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Penserra Capital Management held 1,162 positions worth $5.41B, up 28% from $4.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Penserra Capital Management deployed $984M of net new capital in Q1 2021, opening 152 new positions and adding to 695 existing holdings. Its largest new stake was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Futu Holdings, an estimated $21.6M trimmed.
- Penserra Capital Management's largest Q1 2021 buy was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.
- Penserra Capital Management added most to Alibaba in Q1 2021, an estimated $64.8M increase.
- Penserra Capital Management's biggest Q1 2021 reduction was Futu Holdings, cutting an estimated $21.6M.
- Penserra Capital Management fully exited abrdn Total Dynamic Dividend Fund in Q1 2021, selling an estimated $12.1M.
- Penserra Capital Management's ten largest holdings make up 20% of its $5.41B portfolio in Q1 2021.
- Penserra Capital Management opened 152 new positions and closed 54 in Q1 2021.
- Penserra Capital Management's portfolio value rose 28% quarter-over-quarter to $5.41B.
Based on Penserra Capital Management's 13F filing for Q1 2021, filed 13 May 2021.